[
Amunjela J.N., Tucker S.J. (2017). POPDC1 is suppressed in human breast cancer tissues and is negatively regulated by EGFR in breast cancer cell lines. Cancer Lett., 406: 81–92.
]Search in Google Scholar
[
Amunjela J.N., Swan A.H., Brand T. (2019). The role of the popeye domain containing gene family in organ homeostasis. Cells, 8: 1594.
]Search in Google Scholar
[
Cheng Z., Guo J., Chen L., Luo N., Yang W., Qu X. (2016). Knockdown of EHF inhibited the proliferation, invasion and tumorigenesis of ovarian cancer cells. Mol. Carcinog., 55: 1048–1059.
]Search in Google Scholar
[
Cochrane C.A. (1997). Models in vivo of wound healing in the horse and the role of growth factors. Vet. Dermatol., 8: 259–272.
]Search in Google Scholar
[
Cui R., Cao G., Bai H., Zhang Z. (2019). LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cyst-adenocarcinoma by activating the PI3K/AKT signaling pathway. Cancer Cell Int., 19: 201.
]Search in Google Scholar
[
Dutta S., Wang F.Q., Wu H.S., Mukherjee T.J., Fishman D.A. (2011). The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC). Gynecol. Oncol., 123: 129–137.
]Search in Google Scholar
[
Farré D., Roset R., Huerta M., Adsuara J.E., Roselló L., Albà M.M., Messeguer X. (2003). Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res., 31: 3651.
]Search in Google Scholar
[
Feng Q., Hawes S.E., Stern J.E., Wiens L., Lu H., Zhao M.D., Jordan C.D., Kiviat N.B., Vesselle H. (2008). DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol, Biomarkers Prev., 17: 645–654.
]Search in Google Scholar
[
Funiciello B., Roccabianca P. (2020). Equine Sarcoid. In: Equine Science, Rutland C., Rizvanov A. (eds). IntechOpen.
]Search in Google Scholar
[
Geraldo L.H.M., Spohr T.C.L.S., Amaral R.F.D., Fonseca A.C.C.D., Garcia C., Mendes F.A., Freitas C., dosSantos M.F., Lima F.R.S. (2021). Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies. Signal Transduct. Target Ther., 6: 45.
]Search in Google Scholar
[
Hainisch E.K., Jindra C., Reicher P., Miglinci L., Brodesser D.M., Brandt S. (2022). Bovine papillomavirus type 1 or 2 virion-infected primary fibroblasts constitute a near-natural equine sarcoid model. Viruses, 14: 2658.
]Search in Google Scholar
[
Hanson R.R. (2008). Complications of equine wound management and dermatologic surgery. Vet. Clin. North Am. Equine Pract., 24: 663–696.
]Search in Google Scholar
[
Huang R., Li L., Wang Z., Shen K. (2022). A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer. Front. Oncol., 12: 3839.
]Search in Google Scholar
[
Jindra C., Hainisch E.K., Brandt S. (2023). Immunotherapy of equine sarcoids − from early approaches to innovative vaccines. Vaccines (Basel), 11: 769.
]Search in Google Scholar
[
Jjingo D., Conley A.B., Yi S. V., Lunyak V. V., King Jordan I. (2012). On the presence and role of human gene-body DNA methylation. Oncotarget, 3: 462.
]Search in Google Scholar
[
Kaleibar M.T., Eshghi D., Helan J.A. (2015). A survey on the status of equine skin tumors and associated epidemiological factors in Iran. Comp. Clin. Path., 24: 1407–1415.
]Search in Google Scholar
[
Kim M., Jang H.R., Haam K., Kang T.W., Kim J.H., Kim S.Y., Noh S.M., Song K.S., Cho J.S., Jeong H.Y., Kim J.C., Yoo H.S., Kim Y.S. (2010). Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hyper-methylation in gastric cancer. Carcinogenesis, 31: 1685–1693.
]Search in Google Scholar
[
Knottenbelt D.C. (2005). A suggested clinical classification for the equine sarcoid. Clin. Tech. Equine Pract., 4: 278–295.
]Search in Google Scholar
[
Leakey T.I., Zielinski J., Siegfried R.N., Siegel E.R., Fan C.Y., Cooney C.A. (2008). A simple algorithm for quantifying DNA methylation levels on multiple independent CpG sites in bisulfite genomic sequencing electropherograms. Nucleic Acids Res., 36: e64.
]Search in Google Scholar
[
Lian B.S.X., Kawasaki T., Kano N., Ori D., Ikegawa M., Isotani A., Kawai T. (2022). Regulation of Il6 expression by single CpG methylation in downstream of Il6 transcription initiation site. iScience, 25: 104118.
]Search in Google Scholar
[
Lin Y.H., Lin Y.C., Chen C.C. (2021). Lysophosphatidic acid receptor antagonists and cancer: The current trends, clinical implications, and trials. Cells, 10: 1629.
]Search in Google Scholar
[
Mallona I., Díez-Villanueva A., Peinado M.A. (2014). Methylation plotter: A web tool for dynamic visualization of DNA methylation data. Source Code. Biol. Med., 9: 1–5.
]Search in Google Scholar
[
Messeguer X., Escudero R., Farré D., Núñez O., Martínez J., Albà M.M. (2002). PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics, 18: 333–334.
]Search in Google Scholar
[
Nasir L., Campo M.S. (2008). Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet. Dermatol., 19: 243–254.
]Search in Google Scholar
[
Nishiyama A., Nakanishi M. (2021). Navigating the DNA methylation landscape of cancer. Trends. Genet., 37: 1012–1027.
]Search in Google Scholar
[
Okano M., Bell D.W., Haber D.A., Li E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99: 247–257.
]Search in Google Scholar
[
Park S.Y., Jeong K.J., Panupinthu N., Yu S., Lee J., Han J.W., Kim J.M., Lee J.S., Kang J., Park C.G., Mills G.B., Lee H.Y. (2011). Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene, 30: 1351–1359.
]Search in Google Scholar
[
Pawlina-Tyszko K., Gurgul A., Szmatoła T., Ropka-Molik K., Semik-Gurgul E., Klukowska-Rötzler J., Koch C., Mählmann K., Bugno-Poniewierska M. (2017). Genomic landscape of copy number variation and copy neutral loss of heterozygosity events in equine sarcoids reveals increased instability of the sarcoid genome. Biochimie, 140: 122–132.
]Search in Google Scholar
[
Semik E., Gurgul A., Ząbek T.Z., Ropka-Molik K., Koch C., Mähl-mann K., Bugno-Poniewierska M. (2017). Transcriptome analysis of equine sarcoids. Vet. Comp. Oncol., 15: 1370–1381.
]Search in Google Scholar
[
Semik-Gurgul E. (2021). Molecular approaches to equine sarcoids. Equine Vet. J., 53: 221–230.
]Search in Google Scholar
[
Semik-Gurgul E., Szmatoła T., Gurgul A., Pawlina-Tyszko K., Gałuszka A., Pędziwiatr R., Witkowski M., Ząbek T. (2023). Methylome and transcriptome data integration reveals aberrantly regulated genes in equine sarcoids. Biochimie, 213: 100–113.
]Search in Google Scholar
[
Shi J., Jiang D., Yang S., Zhang X., Wang J., Liu Y., Sun Y., Lu Y., Yang K. (2020). LPAR1, correlated with immune infiltrates, is a potential prognostic biomarker in prostate cancer. Front. Oncol., 10: 846.
]Search in Google Scholar
[
Sobiak B., Leśniak W. (2019). The effect of single CpG demethylation on the pattern of DNA-protein binding. Int. J. Mol. Sci., 20: 914.
]Search in Google Scholar
[
Tsujiuchi T., Okabe K., Fukushima N. (2011). Genetic and epigenetic alterations of lysophosphatidic acid receptor genes in rodent tumors by experimental models. J. Toxicol. Pathol., 24: 143.
]Search in Google Scholar
[
Vohra M., Adhikari P., Souza S.C.D., Nagri S.K., Umakanth S., Satyamoorthy K., Rai P.S. (2020 a). CpG-SNP site methylation regulates allele-specific expression of MTHFD1 gene in type 2 diabetes. Lab. Invest., 100: 1090–1101.
]Search in Google Scholar
[
Vohra M., Sharma A.R., Prabhu B.N., Rai P.S. (2020 b). SNPs in sites for DNA methylation, transcription factor binding, and miRNA targets leading to allele-specific gene expression and contributing to complex disease risk: A systematic review. Pub. Health Genom., 23: 155–170.
]Search in Google Scholar
[
Wang L., Ai M., Nie M., Zhao Li, Deng G., Hu S., Han Y., Zeng W., Wang Y., Yang M., Wang S. (2020). EHF promotes colorectal carcinoma progression by activating TGF-β1 transcription and canonical TGF-β signaling. Cancer Sci., 111: 2310–2324.
]Search in Google Scholar
[
Wang Q., Xiong F., Wu G., Liu W., Chen J., Wang B., Chen Y. (2022). Gene body methylation in cancer: molecular mechanisms and clinical applications. Clin. Epigenet., 14: 1–14.
]Search in Google Scholar
[
Yang X., Han H., DeCarvalho D.D., Lay F.D., Jones P.A., Liang G. (2014). Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell, 26: 577–590.
]Search in Google Scholar
[
Yegnasubramanian S., Haffner M.C., Zhang Y., Gurel B., Cornish T.C., Wu Z., Irizarry R.A., Morgan J., Hicks J., DeWeese T.L., Isaacs W.B., Bova G.S., De Marzo A.M., Nelson W.G. (2008). DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res., 68: 8954–8967.
]Search in Google Scholar
[
Yuan Z.Q., Gobeil P.A.M., Campo M.S., Nasir L. (2010). Equine sarcoid fibroblasts over-express matrix metalloproteinases and are invasive. Virology, 396: 143–151.
]Search in Google Scholar
[
Yung Y.C., Stoddard N.C., Chun J. (2014). Thematic review series: lysophospholipids and their receptors: LPA receptor signaling: pharmacology, physiology, and pathophysiology. J. Lipid. Res., 55: 1192.
]Search in Google Scholar
